PFOS-Induced Ferroptosis and ER Stress in Human Kidney Cells: Mechanistic Insights

Study Background and Research Question

Perfluorooctane sulfonate (PFOS) is a persistent organic pollutant with widespread industrial use, including in food packaging, textiles, and non-stick cookware. Due to its environmental stability and bioaccumulative properties, PFOS has become an international concern and is now regulated under the Stockholm Convention on Persistent Organic Pollutants. Despite restrictions, PFOS continues to be detected in the environment and in human tissues, with drinking water being a primary route of exposure. The kidney, as the main excretory organ for PFOS, is particularly vulnerable to its potential toxic effects. While epidemiological and animal studies have suggested links between PFOS exposure and renal abnormalities, the cellular mechanisms underlying PFOS-induced kidney injury remain incompletely understood.

The reference study (Yan et al., 2024) focuses on elucidating how PFOS damages human proximal tubular epithelial cells (HK-2), with a particular emphasis on two pivotal stress pathways: ferroptosis—a form of iron-dependent, non-apoptotic cell death—and endoplasmic reticulum (ER) stress, which governs cellular protein homeostasis. The central research question is: How does PFOS exposure drive injury in human kidney cells, and what are the roles of ferroptosis and ER stress in this process?

Key Innovation from the Reference Study

The major innovation of this work lies in its clear experimental demonstration that PFOS-induced injury in HK-2 cells is mediated through both ferroptosis and ER stress pathways. By combining cellular viability assays, oxidative stress measurements, and protein expression analyses, the authors provide direct evidence linking PFOS exposure to disruptions in iron metabolism, lipid peroxidation, and unfolded protein response signaling. Specifically, the study identifies an upregulation of kidney injury molecule-1 (KIM-1) and ER stress–related proteins (GRP78, ATF6, IRE1, PERK) as hallmarks of PFOS toxicity, and correlates these with biochemical markers indicative of ferroptotic cell death.

Methods and Experimental Design Insights

Yan et al. utilized human proximal tubular epithelial cells (HK-2) as an in vitro model to replicate the renal cellular environment. Cells were exposed to 200 μM PFOS to simulate toxicant challenge, with or without the ferroptosis inhibitor ferrostatin-1 (1 μM) as a control for cell death pathway specificity. The experimental endpoints included:

• Cell viability assays to assess cytotoxicity.
• Measurement of malondialdehyde (MDA) and intracellular iron as markers of lipid peroxidation and ferroptosis.
• Quantification of glutathione (GSH) and glutathione peroxidase 4 (GPX-4) levels, key components in cellular antioxidant defense.
• Western blot analysis for KIM-1 and ER stress markers (GRP78, ATF6, IRE1, PERK).

This multifaceted approach allowed the authors to dissect the relative contributions of ferroptosis and ER stress to PFOS-induced renal injury. Notably, the inclusion of ferrostatin-1 provided crucial mechanistic specificity, distinguishing ferroptosis-dependent effects from general cytotoxicity.

Core Findings and Why They Matter

Key findings from the study include:

• Increased markers of ferroptosis: PFOS exposure led to significant elevations in intracellular iron and MDA, concurrent with reductions in GSH and GPX-4. These changes are consistent with the induction of ferroptosis (Yan et al., 2024).
• Activation of ER stress pathways: HK-2 cells treated with PFOS showed increased expression of classical ER stress markers, including GRP78, ATF6, IRE1, and PERK. These proteins are key regulators of the unfolded protein response (UPR), which is activated in response to protein misfolding and ER dysfunction.
• Renal injury signature: KIM-1, a clinically relevant marker of kidney tubular damage, was upregulated following PFOS treatment, linking these molecular events to pathophysiological outcomes.

These findings are significant because they establish a causal chain from PFOS exposure to renal epithelial injury via defined molecular pathways. The identification of ferroptosis and ER stress as central mediators suggests that interventions targeting these pathways could mitigate PFOS-induced nephrotoxicity. This is particularly relevant for researchers investigating chemical chaperones or ER stress inhibitors for kidney injury models.

Comparison with Existing Internal Articles

Complementary literature on ER stress modulation, such as the internal article "4-Phenylbutyric Acid: Advanced Modulation of ER Stress and Related Disease Pathways", details how 4-Phenylbutyric acid (4-PBA) acts as a chemical chaperone to alleviate ER stress and influence cell fate decisions like apoptosis and autophagy. While the reference study by Yan et al. does not directly test 4-PBA, the mechanistic overlap is clear: both sources highlight the unfolded protein response as a critical node in cellular stress and injury. Another internal resource, "4-Phenylbutyric Acid: Applied Workflows for ER Stress Modulation", provides protocol-driven guidance for using 4-PBA to modulate ER stress in kidney models, further reinforcing the translational relevance of the reference study’s findings to experimental therapeutics and workflow optimization.

Limitations and Transferability

While the study offers strong cellular evidence for PFOS-induced injury via ferroptosis and ER stress, several limitations should be considered. First, the model system is in vitro, and while HK-2 cells are widely used as a proxy for human renal epithelium, they do not fully recapitulate the complexity of in vivo kidney tissue. Second, the PFOS concentration (200 μM) used in the experiments may exceed typical human exposure levels, though it is appropriate for mechanistic studies. Third, the study does not directly test interventions (e.g., chemical chaperones like 4-PBA) that could mitigate ER stress-driven injury, leaving the therapeutic translation to future work.

Nevertheless, the transferability of these findings is high for researchers designing cell-based assays to dissect ER stress and ferroptosis in toxicology, pharmacology, or nephrology research. The identification of specific marker proteins and stress pathways provides actionable targets for intervention and workflow development.

Protocol Parameters

• PFOS exposure in HK-2 cells: 200 μM for 24 hours to induce ER stress and ferroptosis-related injury.
• Ferroptosis inhibition: Co-treatment with 1 μM ferrostatin-1 to confirm pathway specificity.
• Recommended ER stress modulation (based on related protocols): 4-Phenylbutyric acid can be used at concentrations ranging from 0.5–5 mM in cell culture; solubilize in DMSO or ethanol according to product information for optimal stability and efficacy.
• Protein marker quantification: Assess GRP78, ATF6, IRE1, PERK, and KIM-1 expression via western blot or immunoassay at defined time points post-treatment.

Research Support Resources

Researchers aiming to model or modulate ER stress and ferroptosis in kidney or other cell types can leverage advanced tools such as 4-Phenylbutyric acid (SKU C6831), a validated chemical chaperone for ER stress alleviation and apoptosis research. High-purity 4-PBA from APExBIO is supported by quality control data and workflow recommendations, making it suitable for robust endoplasmic reticulum stress pathway studies and related cellular stress assays. For deeper insight into protocol optimization and experimental troubleshooting, the internal article "4-Phenylbutyric Acid: Applied Workflows for ER Stress Research" provides additional guidance for integrating 4-PBA into advanced cellular models.